Lance Armstrong Facing Suit Over Supplement Ads

March 1 (Bloomberg) -- Bloomberg's Sara Eisen reports that cyclist Lance Armstrong and nutritional products maker FRS Co. were accused of false advertising by linking Armstrong’s Tour de France victories to FRS’s products. She speaks on Bloomberg Television's "Bloomberg Surveillance."
What Makes Mylan Worth $40.1B to Teva Pharmaceuticals?
24:23 - Teva Pharmaceuticals has submitted a $40.1 billion unsolicited offer for Mylan in what would be this year’s largest takeover in the pharmaceutical industry. Bloomberg’s David Wainer and Drew Armstrong examine the bid on “Market Makers.” (Source: Bloomberg)
  • DuPont Profit Beats Ahead of Activist Proxy Showdown
  • El-Erian Says Greece, Creditors Heading Toward `Accident'
  • Google Makes Mobile a Priority in New Search Algorithm